Statistical considerations for the HPTN 052 Study to evaluate the effectiveness of early versus delayed antiretroviral strategies to prevent the sexual transmission of HIV-1 in serodiscordant couples

Contemporary Clinical Trials

Volumn 33, Issue 6, 2012, Pages 1280-1286

  Chen, Ying Qing ^a   Masse, Benoit ^b   Wang, Lei ^a   Ou, San San ^a   Li, Xin ^a   Donnell, Deborah ^a   McCauley, Marybeth ^c   Gamble, Theresa ^c   Ribauldo, Heather J ^d   Cohen, Myron S ^e   Fleming, Thomas R ^f  

^a USA   (United States)

^b UNIVERSITY OF MONTREAL   (Canada)

^c FAMILY HEALTH INTERNATIONAL   (United States)

^d CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antiretroviral therapy; Durability; Multinational; Partner; Treatment as prevention

Indexed keywords

ANTIRETROVIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENETIC LINKAGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTERMETHOD COMPARISON; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SEXUAL TRANSMISSION; TREATMENT PLANNING;

ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; DRUG ADMINISTRATION SCHEDULE; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; SEXUAL PARTNERS; TIME FACTORS;

EID: 84867221491     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2012.07.007     Document Type: Article

References (7)

1. Cohen M.S., Chen Y.Q., McCauley M., Gamble T., Hosseinipour M.C., Kumarasamy N., et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011, 365:493-505.
2. Eshleman S., Hudelson S., Redd A., Wang L., Debes R., Chen Y.Q., et al. Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial. J Infect Dis 2011, 204:1918-1926.
3. DeMets D.L., Lan K.K. Interim analysis: the alpha spending function approach. Stat Med 1994, 13:1341-1352.
4. O'Brien P.C., Fleming T.R. Multiple-testing procedure for clinical trials. Biometrics 1999, 35:549-556.
5. Emerson S.S., Fleming T.R. Symmetric group sequential test designs. Biometrics 1989, 45:905-923.
6. Liang K.-Y., Self S.G., Liu X.H. The Cox proportional hazards model with change point - an epidemiologic application. Biometrics 1990, 3:783-793.
7. Chen Y.Q., Rohde C.A., Wang M.-C. Additive hazards models with latent treatment effectiveness lag time. Biometrika 2002, 89:914-931.